DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ben Goldacre
Ben Goldacre
The Opportunities and Challenges of Pragmatic Point-Of-Care Randomised Trials Using Routinely Collected Electronic Records: Evaluations of Two Exemplar Trials
Homeopathy Works, Then Obviously the Less You Use It, the Stronger It Gets
Transparency in the Time of Constant Change
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients by Ben Goldacre
Drugs, Money and Misleading Evidence
Philip Mirowski, Never Let a Serious Crisis Go to Waste: How Neoliberalism Survived the Financial Meltdown, New York: Verso, 2013
Histories of Medical Lobbying’
On the Clear Evidence of the Risks to Children from Non-Ionizing Radio Frequency Radiation: the Case of Digital Technologies in the Home, Classroom and Society
The Moral Economy of the Pharmaceutical Industry: Legitimising Prices
Ben Goldacre
Evidence Check 2: Homeopathy
Head to Head BMJ: First Published As 10.1136/Bmj.F1880 on 9 July 2013
Number of Nutritional Claims for Regulatory Action
Is Data Speech?
Test, Learn, Adapt: Developing Public Policy with Randomised Controlled Trials
Breaking News
The Pioneers of Transparency
Ben Goldacre: Battling Bad Science
Top View
The Politics of Evidence: from Evidence- Based Policy to the Good Governance of Evidence
Management of Frozen Shoulder: a Systematic Review and Cost-Effectiveness Analysis
Introductory Reading for Biomedical Sciences
Scientific U-Turns: Eight Occasions When Science Changed Its Mind Michael Hal Sosabowski and Paul R
Bad Science: Quacks, Hacks, and Big Pharma Flacks by Ben Goldacre
The Opportunities and Challenges of Pragmatic Point-Of-Care Randomised Trials Using Routinely Collected Electronic Records: Evaluations of Two Exemplar Trials
A Skeptical Eye on Psi
Interpretive Bias in Acupuncture Research? a Case Study
The Firepower of the EU Pharmaceutical Lobby and Implications for Public Health 1
Testin G Tr E a Tm E N Ts
Homeopathy — a Case in Point Why EBM Is So Important — Or, “The Plural of Anecdote Is Not Data.”303
Science Is the New Politics: Evan Harris the Bigger Picture
Big Pharma: Private Profit Before Public Health
Over the Wall
Biased Under-Reporting of Research Reflects
Benefits and Risks of Homoeopathy: a Rejoinder to the Article Published in the Lancet Prof
32Nd ICPE Final Program
CBT: the Cognitive Behavioural Tsunami
The Firepower of the EU Pharmaceutical Lobby and Implications for Public Health 1
Ben Goldacre
Goldacre, B (2009) Is the Conflict of Interest Unacceptable When Drug
Bad Pharma Book Review.Indd
Responding to the Childhood Vaccination Crisis
What Doctors Don't Know About the Drugs They Prescribe
Arxiv:1703.10090V1 [Cs.CL]
Regulation of Agriculture
Download Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients PDF
The Need to Take Action on Clinical Trials Transparency
Organizational Strategy Under Institutional Pluralism
The HRA Interest in Good Research Conduct Transparent
Dear Politicians Can You Imagine Sitting at a Table with the Highest
Building Evidence Into Education Ben Goldacre March 2013
What Big Food Is Hiding with Its Slick PR Campaign on Gmos
Pharmaceutical Trials and Bias
Catalogue of Bias: Publication Bias
No Such Thing As a Free Lunch
GHOST-MANAGED MEDICINE Big Pharma’S Invisible Hands
Medicine for All